BRCA1 and neoplasm: Among tumor samples, those without BRCA1 mutations showed stronger hypomethylation (t-test, P < 10− 100 for all comparisons, Fig. 2C), suggesting the extent of global hypomethylation may vary with the molecular characteristics of the tumor.